Donatienne Taylor: Influence Statistics - Université catholique de Louvain CHU UCL Belgium

Donatienne Taylor

Université catholique de Louvain, CHU UCL Namur—Site Sainte-Elisabeth, Namur, Belgium | CHU UCL Namur, Site Sainte‐Elisabeth, Namur, Belgium

Known for:

Breast Cancer | Endocrine Therapy| Her2 Blockade| Postmenopausal Patients| Neoadjuvant Palbociclib

Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile https://www.keyopinionleaders.com/Breast-Cancer/Donatienne-Taylor-Universit%C3%A9-Catholique-De-Louvain-Chu-Uc-d7c61c0999cf01e76f3695068c5ab20d-ek.html

Donatienne Taylor:Expert Impact

Concepts for whichDonatienne Taylorhas direct influence:Breast cancer,Endocrine therapy,Her2 blockade,Postmenopausal patients,Neoadjuvant palbociclib,Study treatment,Ethinyl estradiol.

Donatienne Taylor:KOL impact

Concepts related to the work of other authors for whichfor which Donatienne Taylor has influence:Ctdna patients,Esmo recommendations,Tumour dna assays,Evidence clinical utility,Development routine practice.

KOL Resume for Donatienne Taylor

Year
2022	Université catholique de Louvain, CHU UCL Namur—Site Sainte-Elisabeth, Namur, Belgium

Key People For Breast Cancer

Top KOLs in the world

Ahmedin M Jemal

united states breast cancer addis ababa

Gabriel N Hortobagyi

breast cancer neoadjuvant chemotherapy estrogen receptors

Rebecca L Siegel

united states colorectal cancer incidence rates

Charles M Perou

breast cancer gene expression intrinsic subtypes

Freddie Ian Bray

cancer incidence nordic countries mortality rates

Jacques Ferlay

cancer incidence global burden latin america

Select a search phrase breast cancer , breast cancer cells , breast cancer patients , breast cancer risk , breast cancers